Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
CORONA Remedies Limited (NSE: CORONA), ISIN INE02ZQ01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CORONA last traded at ₹2545.40 (+4.27%), with a 52-week range of ₹1336.60 to ₹2687.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 69.00%, FIIs 4.21%, DIIs 16.44%, mutual funds 16.06%.
EquiSense Score (ECS): 46/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.